Dimensional Fund Advisors’s Immunome IMNM Stock Holding History

Dimensional Fund Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.8M	Buy	367,967 +334,559	+1,001%	+$7.16M	﹤0.01%	2408
2026 Q1	$731K	Sell	33,408 -282,975	-89%	-$6.3M	﹤0.01%	2892
2025 Q4	$6.8M	Sell	316,383 -21,972	-6%	-$386K	﹤0.01%	2427
2025 Q3	$3.96M	Buy	338,355 +233,571	+223%	+$2.32M	﹤0.01%	2606
2025 Q2	$974K	Buy	+104,784	New	+$859K	﹤0.01%	2892
2024 Q1	–	Sell	-14,054	Closed	-$150K	–	3417
2023 Q4	$150K	Sell	14,054 -1,379	-9%	-$11.5K	﹤0.01%	3234
2023 Q3	$129K	Hold	15,433	–	–	﹤0.01%	3285
2023 Q2	$122K	Hold	15,433	–	–	﹤0.01%	3301
2023 Q1	$77K	Buy	+15,433	New	+$75.5K	﹤0.01%	3341

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Dimensional Fund Advisors's IMNM Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Immunome (IMNM) stake by 1,001% in Q2 2026, buying an estimated $7.16M and bringing the position to 367,967 shares worth $7.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

Dimensional Fund Advisors first reported a position in IMNM in Q1 2023 and has held it in 9 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Dimensional Fund Advisors held 367,967 shares of Immunome worth $7.8M as of Q2 2026.
Dimensional Fund Advisors bought 334,559 Immunome shares in Q2 2026, an estimated $7.16M.
Immunome made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2408 holding.
Dimensional Fund Advisors first reported a position in Immunome in Q1 2023 and has held it in 9 quarters since.
202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.